PFF Summit Highlights: News You Can Use
| Overview / Abstract: |
Across three brief videos, expert faculty Dr. Joseph Lasky discusses highlights and data from the PFF Summit 2021, which took place virtually. Dr. Lasky provides insights into updated diagnostic guidance, emerging therapies, and patient perspectives across the spectrum of interstitial lung diseases (ILD). Don’t miss this opportunity to hear the latest research in ILD! A differential diagnosis of ILD can be challenging and patients often experience delays, but an accurate diagnosis is necessary to guide therapy selection. Once diagnosed, patients require a comprehensive care plan that includes pharmacotherapy and supportive care. A number of additional agents are also under investigation across the ILDs to expand options for patients. As such, the multidisciplinary team requires up-to-date information to ensure that patients receive the latest care. |
|
Expiration |
Nov 17, 2022 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
.50 AMA PRA Category 1 Credit(s)™ |
|
Accreditation |
ACCME |
|
Presenters / Authors / Faculty |
Joseph Lasky, MD |
|
Activity Specialities / Related Topics |
Cardiology / Cardiovascular, Pulmonary Medicine / COPD |
|
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Genentech, Inc. |
|
Keywords / Search Terms |
ACHL CME, CE, PFF, pulmonary fibrosis, Virtual Summit, Joseph Lasky, Lasky, Tulane, interstitial lung disease, ILD, CTD-ILD, COPD, differential diagnosis, treatment selection, ATS, ACCP, emerging data, Ryerson, Johannson, lung biopsy, cryobiopsy, molecular classifier, connective tissue disease, CTD, Wilfong, Nintedanib, antifibrotic therapy, Corte, Pathogenesis, Acute Exacerbations, Progressive Fibrosis, Pamrevlumab, ZEPHYRUS, PAH Free CE CME |
|